Literature DB >> 7685599

Angiogenic effects of advanced glycation end products of the Maillard reaction on cultured human umbilical cord vein endothelial cells.

M Tezuka1, N Koyama, N Morisaki, Y Saito, S Yoshida, N Araki, S Horiuchi.   

Abstract

The effects of advanced glycation end products (AGE) of the Maillard reaction on proliferation, migration and angiogenesis of cultured human umbilical vein endothelial cells (HUVEC) were studied. In an in vitro angiogenesis system, tube formation of HUVEC was dose-dependently stimulated by AGE at 0.5-50 micrograms/ml. Migration of HUVEC was also stimulated by AGE in a similar concentration range, and checkerboard analysis revealed that AGE were chemotactic but not chemokinetic. Proliferation of HUVEC was not affected by AGE. These data provide evidence that AGE are angiogenic.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7685599     DOI： 10.1006/bbrc.1993.1677

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  Effective components of Chinese herbal compound decoction and Maillard reaction.

Authors:  Zhi-yun Cao; Xu-zheng Chen; En-ta Chang; Jian Du
Journal:  Chin J Integr Med       Date:  2009-07-02       Impact factor: 1.978

2.  Tuning three-dimensional collagen matrix stiffness independently of collagen concentration modulates endothelial cell behavior.

Authors:  Brooke N Mason; Alina Starchenko; Rebecca M Williams; Lawrence J Bonassar; Cynthia A Reinhart-King
Journal:  Acta Biomater       Date:  2012-08-16       Impact factor: 8.947

3.  Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advanced glycation endproduct-modified serum albumins.

Authors:  M E Westwood; P J Thornalley
Journal:  J Protein Chem       Date:  1995-07

4.  Mechanism of angiogenic effects of saponin from ginseng Radix rubra in human umbilical vein endothelial cells.

Authors:  N Morisaki; S Watanabe; M Tezuka; M Zenibayashi; R Shiina; N Koyama; T Kanzaki; Y Saito
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

5.  Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease.

Authors:  U Ritthaler; Y Deng; Y Zhang; J Greten; M Abel; B Sido; J Allenberg; G Otto; H Roth; A Bierhaus
Journal:  Am J Pathol       Date:  1995-03       Impact factor: 4.307

6.  Advanced glycation end products of bovine serum albumin-induced endothelial-to-mesenchymal transition in cultured human and monkey endothelial cells via protein kinase B signaling cascades.

Authors:  Jianli Ma; Ting Liu; Xiaoguang Dong
Journal:  Mol Vis       Date:  2010-12-09       Impact factor: 2.367

7.  Advanced glycation end products induce endothelial-to-mesenchymal transition via downregulating Sirt 1 and upregulating TGF-β in human endothelial cells.

Authors:  Wei He; Jian Zhang; Tian-yi Gan; Guo-jun Xu; Bao-peng Tang
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

8.  Advanced Glycation End Products Inhibit the Proliferation of Human Umbilical Vein Endothelial Cells by Inhibiting Cathepsin D.

Authors:  Yuan Li; Ye Chang; Ning Ye; Dongxue Dai; Yintao Chen; Naijin Zhang; Guozhe Sun; Yingxian Sun
Journal:  Int J Mol Sci       Date:  2017-02-17       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.